CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-19 | Gayron Kenneth L Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2021-04-19 | Shapiro Aron Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2021-04-08 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −899 | $4.94 | $4K | 71,949 |
| 2021-04-08 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −180 | $4.94 | $889 | 23,933 |
| 2021-04-08 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −194 | $4.94 | $958 | 15,916 |
| 2021-04-08 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −192 | $4.94 | $948 | 15,884 |
| 2021-03-03 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −898 | $5.46 | $5K | 72,848 |
| 2021-03-03 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −218 | $5.46 | $1K | 24,113 |
| 2021-03-03 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −192 | $5.46 | $1K | 16,110 |
| 2021-03-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −192 | $5.46 | $1K | 16,076 |
| 2021-02-02 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −990 | $6.34 | $6K | 16,302 |
| 2021-02-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −988 | $6.34 | $6K | 16,268 |
| 2021-02-02 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −3,542 | $6.34 | $22K | 73,746 |
| 2021-02-02 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −1,282 | $6.34 | $8K | 24,331 |
| 2021-02-01 | MANZO MICHAEL P. VP of Engineering | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-02-01 | Mann Brenda VP of Research & Development | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-02-01 | FROM STEPHEN Executive Chairman | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-02-01 | Romano Sarah Chief Financial Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-02-01 | TYLE PRAVEEN Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2021-02-01 | HANCOCK THOMAS Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 |
Page 8 of 13 · 244 trades